Development and validation of the French ASQoL questionnaire

Clinical and Experimental Rheumatology

Volumn 28, Issue 3, 2010, Pages 379-385

  Pham, Thao ^a   Van Der Heijde, Désirée M ^b   Pouchot, Jacques ^c,d   Guillemin, Francis ^c,e,f  

^a APHM   (France)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITÉ DE LORRAINE   (France)

^d HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^e INSERM   (France)

^f UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

Ankylosing spondylitis; Cultural adaptation; Rasch model

Indexed keywords

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; ASQOL QUESTIONNAIRE; DISEASE ACTIVITY; FEMALE; FRANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SELF REPORT; CULTURAL ANTHROPOLOGY; CULTURAL FACTOR; DISABILITY; HEALTH STATUS; LANGUAGE; PATHOPHYSIOLOGY; REPRODUCIBILITY; STANDARD; VALIDATION STUDY;

CROSS-CULTURAL COMPARISON; CULTURE; DISABILITY EVALUATION; FRANCE; HEALTH STATUS; HUMANS; LANGUAGE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SPONDYLITIS, ANKYLOSING;

EID: 77956998245     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. BRAUN J, BOLLOW M, REMLINGER G et al.: Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum 1998; 41: 58-67.
2. VAN DER LINDEN SM, VALKENBURG HA, DE JONGH BM, CATS A: The risk of developing ankylosing spondylitis in HLA-B27 positive individuals. A comparison of relatives of spondylitis patients with the general population. Arthritis Rheum 1984; 27: 241-9.
3. SARAUX A, GUILLEMIN F, GUGGENBUHL P et al.: Prevalence of spondyloarthropathies in France: 2001. Ann Rheum Dis 2005; 64: 1431-5.
4. GUILLEMIN F, SARAUX A, GUGGENBUHL P et al.: Prevalence of rheumatoid arthritis in France: 2001. Ann Rheum Dis 2005; 64: 1427-30.
5. ZINK A, BRAUN J, LISTING J, WOLLENHAUPT J: Disability and handicap in rheumatoid arthritis and ankylosing spondylitis-results from the German rheumatological database. German Collaborative Arthritis Centers. J Rheumatol 2000; 27: 613-22.
6. CHAMBERLAIN MA: Socioeconomic effects of ankylosing spondylitis. Int Rehabil Med 1981; 3: 94-9.
7. BOONEN A, VAN DER HEIJDE D, LANDEWE R et al.: Direct costs of ankylosing spondylitis and its determinants: an analysis among three European countries. Ann Rheum Dis 2003; 62: 732-40.
8. WARD MM: Health-related quality of life in ankylosing spondylitis: a survey of 175 patients. Arthritis Care Res 1999; 12: 247-55.
9. BRAUN J, PINCUS T: Mortality, course of disease and prognosis of patients with ankylosing spondylitis. Clin Exp Rheumatol 2002; 20 (Suppl. 28): S16-22.
10. ZOCHLING J, BRAUN J: Quality indicators, guidelines and outcome measures in ankylosing spondylitis. Clin Exp Rheumatol 2007; 25 (Suppl. 47): 147-52.
11. HAYWOOD KL, GARRATT AM, DZIEDZIC K, DAWES PT: Generic measures of health-related quality of life in ankylosing spondylitis: reliability, validity and responsiveness. Rheumatology (Oxford) 2002; 41: 1380-7.
12. BOSTAN EE, BORMAN P, BODUR H, BARCA N: Functional disability and quality of life in patients with ankylosing spondylitis. Rheumatol Int 2003; 23: 121-6.
13. HAYWOOD KL, GARRATT AM, DZIEDZIC K, DAWES PT: Patient centered assessment of ankylosing spondylitis-specific health related quality of life: evaluation of the Patient Generated Index. J Rheumatol 2003; 30: 764-73.
14. ORTIZ Z, SHEA B, GARCIA DIEGUEZ M et al.: The responsiveness of generic quality of life instruments in rheumatic diseases. A systematic review of randomized controlled trials. J Rheumatol 1999; 26: 210-6.
15. DOWARD LC, SPOORENBERG A, COOK SA, et al.: Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis. Ann Rheum Dis 2003; 62: 20-6.
16. HAYWOOD KL, MGARRATT AM, JORDAN K, DZIEDZIC K, DAWES PT: Disease-specific, patient-assessed measures of health outcome in ankylosing spondylitis: reliability, validity and responsiveness. Rheumatology (Oxford) 2002; 41: 1295-302.
17. ACQUADRO C, BERZON R, DUBOIS D et al., PRO HARMONIZATION GROUP: Incorporating the patient's perspective into drug development and communication: an ad hoc task force report of the Patient-Reported Outcomes (PRO) Harmonization Group meeting at the Food and Drug Administration, February 16, 2001. Value Health 2003; 6: 522-31.
18. KIRSHNER B, GUYATT G: A methodological framework for assessing health indices. J Chronic Dis 1985; 38: 27-36.
19. GUILLEMIN F, BOMBARDIER C, BEATON D: Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol 1993; 46: 1417-32.
20. BEATON DE, BOMBARDIER C, GUILLEMIN F, FERRAZ MB: Guidelines for the process of cross-cultural adaptation of self-report measures. Spine 2000; 25: 3186-91.
21. VERDIER A, LEPLEGE A: The pitfalls of backtranslation. In SCHUMAKER S, BERZON R, eds: International use and performance of health-related quality of life instruments, Oxford: Rapid Communication; 1995.
22. PHAM T, LANDEWE R, VAN DER LINDEN S et al.: An international study on starting tumour necrosis factor-blocking agents in ankylosing spondylitis. Ann Rheum Dis 2006; 65: 1620-5.
23. DOUGADOS M, VAN DER LINDEN S, JUHLIN R et al.: The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991; 34: 1218-27.
24. GARRETT S, JENKINSON T, KENNEDY LG, WHITELOCK H, GAISFORD P, CALIN A: in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994; 21: 2286-91.
25. CALIN A, GARRETT S, WHITELOCK H et al.: A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 1994; 21: 2281-5.
26. JONES SD, STEINER A, GARRETT SL, CALIN A: The Bath Ankylosing Spondylitis Patient Global Score (BAS-G). Br J Rheumatol 1996; 35: 66-71.
27. JAESCHKE R, SINGER J, GUYATT GH: Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials 1989; 10: 407-15.
28. RASCH G: Probabilistic models for some intelligence and attainment tests. Copenhagen, Denmark: Danmarks Paedagogiske Institut; 1960.
29. BIRNBAUM A: Some latent traits model and their use in inferring an examinee's ability. In LORD FM, NOVICK MR (Eds.) Statistical theories of mental test scores. Reading, MA: Addison-Wesley; 1968.
30. CRONBACH L: Coefficient alpha and the internal strucure of tests. Psychometrika 1951; 16: 297-334
31. LANDIS JR, KOCH GG: The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-74.
32. MURAKI E, BOCK RD: PARSCALE (version 3.5): parameter scaling of rating data. 1998.
33. WARD MM: Outcome measurement: health status and quality of life. Curr Opin Rheumatol 2004; 16: 96-101.
34. VAN DER HEIJDE D, BELLAMY N, CALIN A, DOUGADOS M, KHAN MA, VAN DER LINDEN S: Preliminary core sets for endpoints in ankylosing spondylitis. Assessments in Ankylosing Spondylitis Working Group. J Rheumatol 1997; 24: 2225-9.
35. GUILLEMIN F, CHALLIER B, URLACHER F, VANCON G, POUREL J: Quality of life in ankylosing spondylitis: validation of the ankylosing spondylitis Arthritis Impact Measurement Scales 2, a modified Arthritis Impact Measurement Scales Questionnaire. Arthritis Care Res 1999; 12: 157-62.
36. MEENAN RF, MASON JH, ANDERSON JJ, GUCCIONE AA, KAZIS LE: AIMS2. The content and properties of a revised and expanded Arthritis Impact Measurement Scales Health Status Questionnaire. Arthritis Rheum 1992; 35: 1-10.
37. ALMODOVAR R, ZARCO P, COLLANTES E et al:. Relationship between spinal mobility and disease activity, function, quality of life and radiology. A cross-sectional Spanish registry of spondyloarthropathies (REGISPONSER). Clin Exp Rheumatol 2009; 27: 439-45.
38. ACQUADRO C, CONWAY K, HAREENDRAN A, AARONSON N; EUROPEAN REGULATORY ISSUES AND QUALITY OF LIFE ASSESSMENT (ERIQA) GROUP: Literature review of methods to translate health-related quality of life questionnaires for use in multinational clinical trials. Value Health 2008; 11: 509-21.
39. DOWARD LC, MCKENNA SP, MEADS DM et al:. Translation and validation of non-English versions of the Ankylosing Spondylitis Quality of Life (ASQOL) questionnaire. Health Qual Life Outcomes 2007; 5: 7.
40. BULLINGER M, ALONSO J, APOLONE G et al.: Translating health status questionnaires and evaluating their quality: the IQOLA Project approach. International Quality of Life Assessment. J Clin Epidemiol 1998; 51: 913-23.
41. WILD D, GROVE A, MARTIN M et al:, ISPOR TASK FORCE FOR TRANSLATION AND CULTURAL ADAPTATION: Principles of Good Practice for the Translation and Cultural Adaptation Process for Patient-Reported Outcomes (PRO) Measures: report of the ISPOR Task Force for Translation and Cultural Adaptation. Value Health 2005; 8: 94-104.
42. FERRAZ MB, OLIVEIRA LM, ARAUJO PM, ATRA E, TUGWELL P: Crosscultural reliability of the physical ability dimension of the health assessment questionnaire. J Rheumatol 1990; 17: 813-7.
43. TERESI JA: Overview of quantitative measurement methods: equivalence, invariance, and differential item functioning in health applications. Med Care 2006; 44 (Suppl. 3): S39-49.
44. DAVIS JC JR, REVICKI D, VAN DER HEIJDE DM, et al:. Health-related quality of life outcomes in patients with active ankylosing spondylitis treated with adalimumab: results from a randomized controlled study. Arthritis Rheum 2007; 57: 1050-7.